SCHEMBL16615519

SCHEMBL16615519

CCCN(CCC)S(=O)(=O)c1ccc(NC(=O)C2c3ccccc3Oc3ccccc32)cc1

nearest known ligand 0.83

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.83
ALDH1A1 P00352 4/20 0.83
LMNA P02545 1/20 0.83
KMT2A Q03164 8/20 0.66
MEN1 O00255 7/20 0.66
TP53 P04637 1/20 0.66
GAA P10253 2/20 0.62
CA12 O43570 4/20 0.55
CA9 Q16790 4/20 0.55
CA1 P00915 2/20 0.55
NPSR1 Q6W5P4 2/20 0.53
POLB P06746 2/20 0.53
TSHR P16473 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
ESR1 P03372 1/20 0.52
CTDSP1 Q9GZU7 1/20 0.52
GLA P06280 1/20 0.52
HTT P42858 1/20 0.51
ABCC9 O60706 1/20 0.49
ABCC8 Q09428 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17947678 0.90 ALDH1A1 (0.74) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL16615819 0.74 LMNA (0.64) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL4189849 0.74 CA9 (0.68) MAPTLMNAKMT2AMEN1GAA
SCHEMBL17947763 0.73 CA9 (0.90) MAPTLMNAKMT2AMEN1GAA
SCHEMBL16615495 0.73 LMNA (0.66) ALDH1A1LMNAKMT2AMEN1CA12
SCHEMBL16615487 0.72 MAPT (0.69) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL16615520 0.70 MAPT (0.66) MAPTALDH1A1KMT2AMEN1TP53
SCHEMBL10119209 0.70 MAPT (0.67) MAPTLMNAKMT2AMEN1GAA
SCHEMBL16615503 0.69 CA12 (0.61) MAPTALDH1A1LMNAKMT2AMEN1
SCHEMBL17947769 0.68 POLB (1.00) MAPTALDH1A1LMNAKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160213679-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF Université de Montréal (CA) 2016-07-28 US disclosed
US-20160213679-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF Université de Montréal (CA) 2016-07-28 US disclosed
WO-2015042685-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF VALORISATION-RECHERCHE (CA) 2015-04-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160213679-A1 INHIBITORS OF POLYNUCLEOTIDE REPEAT-ASSOCIATED RNA FOCI AND USES THEREOF FBL, HNRNPA1, HNRNPUL1 MAPT 417/4885ALDH1A1 4383/4885LMNA 705/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.